59 / 61
1L
2L
3L
Platinum-based chemo
Immunotherapy
Chemo + IO
Platinum-based chemo
Chemo-antiangiogenic
Immunotherapy
Chemo-antiangiogenic
Immunotherapy
Chemo-antiangiogenic
Chemo-antiangiogenic
Chemo-antiangiogenic
Chemo + IO +
Antiangiogenic
Chemo-antiangiogenic
(switch)
Stg III Chemorads
Durvalumab
Chemo-antiangiogenic
DFS <6m
DFS >6m (?) Multiple options
Second line options: Changing scenario